<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04354285</url>
  </required_header>
  <id_info>
    <org_study_id>5/2020</org_study_id>
    <nct_id>NCT04354285</nct_id>
  </id_info>
  <brief_title>24-hour Urinary Aldosterone And Endocrine System In Obesity</brief_title>
  <official_title>24-hour Urinary Aldosterone And Endocrine System In Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was aimed at investigating the relationship between hormone parameters and urinary
      aldosterone levels in 24h within a cohort of overweight and obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects were enrolled at the first examination whether they were not taking any medication,
      including oral contraceptives or drugs for osteoporosis, and free of significant medical
      illnesses, except obesity. Exclusion criteria were history of endocrinological diseases
      (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), chronic inflammatory
      diseases, stable known hypertension, angina pectoris, stroke, transient ischemic attack,
      heart infarction, congenital heart disease, malignancies, chronic inflammatory diseases,
      renal and liver failure, angina pectoris, myocardial infarction, heart failure, congenital
      heart diseases, minor and major stroke, and inherited thrombocytopenias and other major
      malignancies. Subjects were examined by means of the medical history, hormonal, metabolic and
      routine hematochemical parameters. The investigators provided for a clinical baseline
      evaluation that included extemporaneous ambulatory blood pressure (BP) and a physical
      assessment of body weight, Body Mass Index (BMI) and Waist Circumference (WC) as
      anthropometric parameters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thyroid hormones (FT3, FT4)</measure>
    <time_frame>Baseline</time_frame>
    <description>FT3 (pg/mL), FT4 (pg/mL) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TSH</measure>
    <time_frame>Baseline</time_frame>
    <description>TSH (mU/L) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urinary Aldosterone</measure>
    <time_frame>Baseline</time_frame>
    <description>24-h Urine Aldosterone (mg/24 h)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prolactin</measure>
    <time_frame>Baseline</time_frame>
    <description>Prolactin (ng/ml) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin</measure>
    <time_frame>Baseline</time_frame>
    <description>Insulin (mIU/L) concentration in serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parathyroid Hormone</measure>
    <time_frame>Baseline</time_frame>
    <description>PTH (pg/mL) concentration in serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Baseline</time_frame>
    <description>Total cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>Baseline</time_frame>
    <description>HDL cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>Baseline</time_frame>
    <description>LDL cholesterol (mg/dL) concentrations in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>Baseline</time_frame>
    <description>BMI (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>Baseline</time_frame>
    <description>Height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>Baseline</time_frame>
    <description>Vitamin D (ng/mL) concentration in serum</description>
  </secondary_outcome>
  <enrollment type="Actual">230</enrollment>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Observational</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who came to the Outpatient Clinic of Nutrition at the National Institute of
        Gastroenterology &quot;S. de Bellis,&quot; Research Hospital, Castellana Grotte, Italy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obesity (BMI&gt; 25 Kg/m2)

        Exclusion Criteria:

          -  Any kind of drug

          -  Hypertension

          -  Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism,
             etc.),

          -  Chronic inflammatory diseases

          -  Renal failure

          -  Liver failure

          -  Angina pectoris

          -  Myocardial infarction and heart failure

          -  Genetic heart diseases

          -  Thrombocytopenias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>National Institute of Gastroenterology IRCCS S. de Bellis</name>
      <address>
        <city>Castellana Grotte</city>
        <state>Bari</state>
        <zip>70132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</investigator_affiliation>
    <investigator_full_name>Gianluigi Giannelli</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

